Company News, Regulations

Pharma-Grade CBD for Personal Care

USDEA removes Purisys' Cannabidiol from Schedule I of Controlled Substances Act. 

Purisys, LLC, a producer of ultra-high purity cannabinoids, announced today that the US Drug Enforcement Agency has removed its cannabidiol (CBD) from Schedule I of the Controlled Substances Act.    Purisys currently produces all major cannabinoids relevant to pharmaceutical and consumer products (>50), as well as degradants, metabolites and analytical reference standards. In addition to CBD, more than 30 other cannabinoids have also been descheduled.    Purisys has been manufacturing ultra-h...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters